239 related articles for article (PubMed ID: 34117312)
21. Comparative efficacy of live replicating sheeppox vaccine strains in Ovines.
Yogisharadhya R; Bhanuprakash V; Hosamani M; Venkatesan G; Balamurugan V; Bora DP; Bhanot V; Prabhu M; Singh RK
Biologicals; 2011 Nov; 39(6):417-23. PubMed ID: 21993305
[TBL] [Abstract][Full Text] [Related]
22. Sequence analysis of attachment gene of lumpy skin disease and sheep poxviruses.
El-Kenawy AA; El-Tholoth MS
Virol Sin; 2010 Dec; 25(6):409-16. PubMed ID: 21221919
[TBL] [Abstract][Full Text] [Related]
23. Genetically Modified Rabies Virus Vector-Based Rift Valley Fever Virus Vaccine is Safe and Induces Efficacious Immune Responses in Mice.
Zhang S; Hao M; Feng N; Jin H; Yan F; Chi H; Wang H; Han Q; Wang J; Wong G; Liu B; Wu J; Bi Y; Wang T; Sun W; Gao Y; Yang S; Zhao Y; Xia X
Viruses; 2019 Oct; 11(10):. PubMed ID: 31597372
[TBL] [Abstract][Full Text] [Related]
24. Four-segmented Rift Valley fever virus induces sterile immunity in sheep after a single vaccination.
Wichgers Schreur PJ; Kant J; van Keulen L; Moormann RJ; Kortekaas J
Vaccine; 2015 Mar; 33(12):1459-64. PubMed ID: 25665959
[TBL] [Abstract][Full Text] [Related]
25. Safety and efficacy of a mutagen-attenuated Rift Valley fever virus vaccine in cattle.
Morrill JC; Mebus CA; Peters CJ
Am J Vet Res; 1997 Oct; 58(10):1104-9. PubMed ID: 9328662
[TBL] [Abstract][Full Text] [Related]
26. Characterization of sheep pox virus vaccine for cattle against lumpy skin disease virus.
Tuppurainen ES; Pearson CR; Bachanek-Bankowska K; Knowles NJ; Amareen S; Frost L; Henstock MR; Lamien CE; Diallo A; Mertens PP
Antiviral Res; 2014 Sep; 109():1-6. PubMed ID: 24973760
[TBL] [Abstract][Full Text] [Related]
27. Seroprevalence of Rift Valley fever and lumpy skin disease in African buffalo (Syncerus caffer) in the Kruger National Park and Hluhluwe-iMfolozi Park, South Africa.
Fagbo S; Coetzer JA; Venter EH
J S Afr Vet Assoc; 2014 Oct; 85(1):e1-e7. PubMed ID: 25686252
[TBL] [Abstract][Full Text] [Related]
28. [Study on DNA immune of envelope protein gene of Rift Valley Fever Virus].
Wang QH; Wang XJ; Hu S; Ge JY; Bu ZG
Wei Sheng Wu Xue Bao; 2007 Aug; 47(4):677-81. PubMed ID: 17944371
[TBL] [Abstract][Full Text] [Related]
29. Recombinant Rift Valley fever viruses encoding bluetongue virus (BTV) antigens: Immunity and efficacy studies upon a BTV-4 challenge.
Moreno S; Calvo-Pinilla E; Devignot S; Weber F; Ortego J; Brun A
PLoS Negl Trop Dis; 2020 Dec; 14(12):e0008942. PubMed ID: 33275608
[TBL] [Abstract][Full Text] [Related]
30. Further evaluation of a mutagen-attenuated Rift Valley fever vaccine in sheep.
Morrill JC; Carpenter L; Taylor D; Ramsburg HH; Quance J; Peters CJ
Vaccine; 1991 Jan; 9(1):35-41. PubMed ID: 2008798
[TBL] [Abstract][Full Text] [Related]
31. Serological evidence of inter-epizootic/inter-epidemic circulation of Rift Valley fever virus in domestic cattle in Kyela and Morogoro, Tanzania.
Matiko MK; Salekwa LP; Kasanga CJ; Kimera SI; Evander M; Nyangi WP
PLoS Negl Trop Dis; 2018 Nov; 12(11):e0006931. PubMed ID: 30418975
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the safety, immunogenicity and efficacy of three capripoxvirus vaccine strains against lumpy skin disease virus.
Gari G; Abie G; Gizaw D; Wubete A; Kidane M; Asgedom H; Bayissa B; Ayelet G; Oura CA; Roger F; Tuppurainen ES
Vaccine; 2015 Jun; 33(28):3256-61. PubMed ID: 26056063
[TBL] [Abstract][Full Text] [Related]
33. Safety and immunogenicity of inactivated Rift Valley Fever Smithburn viral vaccine in sheep.
Matsiela MS; Naicker L; Khoza T; Mokoena N
Virol J; 2023 Oct; 20(1):221. PubMed ID: 37789354
[TBL] [Abstract][Full Text] [Related]
34. An equine herpesvirus type 1 (EHV-1) vector expressing Rift Valley fever virus (RVFV) Gn and Gc induces neutralizing antibodies in sheep.
Said A; Elmanzalawy M; Ma G; Damiani AM; Osterrieder N
Virol J; 2017 Aug; 14(1):154. PubMed ID: 28807043
[TBL] [Abstract][Full Text] [Related]
35. A Novel Quadruple Gene-Deleted BoHV-1-Vectored RVFV Subunit Vaccine Induces Humoral and Cell-Mediated Immune Response against Rift Valley Fever in Calves.
Pavulraj S; Stout RW; Barras ED; Paulsen DB; Chowdhury SI
Viruses; 2023 Oct; 15(11):. PubMed ID: 38005861
[TBL] [Abstract][Full Text] [Related]
36. A novel triplex real-time PCR assay for the differentiation of lumpy skin disease virus, goatpox virus, and sheeppox virus.
Nan W; Gong M; Lu Y; Li J; Li L; Qu H; Liu C; Wang Y; Wu F; Wu X; Wang Z; Chen Y; Peng D
Front Vet Sci; 2023; 10():1175391. PubMed ID: 37448583
[TBL] [Abstract][Full Text] [Related]
37. Antiviral and protective effect of small interfering RNAs against rift valley fever virus in vitro.
Ahmed EM; Boseila AA; Hanora AS; Solyman SM
Mol Biol Rep; 2023 Jul; 50(7):5837-5848. PubMed ID: 37231214
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of lamb and calf responses to Rift Valley fever MP-12 vaccination.
Wilson WC; Bawa B; Drolet BS; Lehiy C; Faburay B; Jasperson DC; Reister L; Gaudreault NN; Carlson J; Ma W; Morozov I; McVey DS; Richt JA
Vet Microbiol; 2014 Aug; 172(1-2):44-50. PubMed ID: 24856133
[TBL] [Abstract][Full Text] [Related]
39. Rift Valley Fever Virus MP-12 Vaccine Is Fully Attenuated by a Combination of Partial Attenuations in the S, M, and L Segments.
Ikegami T; Hill TE; Smith JK; Zhang L; Juelich TL; Gong B; Slack OA; Ly HJ; Lokugamage N; Freiberg AN
J Virol; 2015 Jul; 89(14):7262-76. PubMed ID: 25948740
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of a recombinant Rift Valley fever virus MP-12 with NSm deletion as a vaccine candidate in sheep.
Weingartl HM; Nfon CK; Zhang S; Marszal P; Wilson WC; Morrill JC; Bettinger GE; Peters CJ
Vaccine; 2014 Apr; 32(20):2345-9. PubMed ID: 24462482
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
